The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2016 | ESMO 2016: Introduction to press briefs and presidential symposia
Andrés Cervantes, MD, PhD of University of Valencia, Valencia, Spain introduces the press conference and the presidential symposia at ESMO 2016. He explains how the 1600 papers that have been accepted, are organized and highlights how there are three presidential symposia due to the wealth of papers. The breakthrough papers are on the Monaleesa 2 study (advanced breast cancer), ENGOT NOVA (ovarian cancer), EORTC 18071 (melanoma), on lung cancer and sarcoma.
Recorded at the 2016 annual meeting of the European Society of Medical Oncology (ESMO), held in Copenhagen, Denmark.
